Cargando…
Regulatory B Cells Are Decreased and Functionally Impaired in Myasthenia Gravis Patients
Myasthenia gravis (MG) is an autoimmune disease mediated by B cells secreting autoantibodies. Regulatory B (Breg) cells confirmed to have an immunosuppressive function play an important role in many autoimmune diseases. However, what about the changes in Breg cells in the thymus and peripheral blood...
Autores principales: | Lin, Ye, Chang, Ting, Lin, Jiaji, Sun, Chenjing, Wei, Chao, Zhao, Jiao, Liu, Rui, Yang, Kun, Li, Zhuyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918563/ https://www.ncbi.nlm.nih.gov/pubmed/35295834 http://dx.doi.org/10.3389/fneur.2022.808322 |
Ejemplares similares
-
Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis
por: Chang, Ting, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis
por: Huang, Yi-Te, et al.
Publicado: (2020) -
Effects of Mitophagy on Regulatory T Cell Function in Patients With Myasthenia Gravis
por: Wang, Na, et al.
Publicado: (2020) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
Lack of Immunotherapy as the Only Predictor of Secondary Generalization in Very-Late-Onset Myasthenia Gravis With Pure Ocular Onset
por: Zhao, Sijia, et al.
Publicado: (2022)